Our engineered cells mimicked both the HS intracellular accumulation observed in neurons of Alzheimer’s disease and the tau aggregation characteristic of tauopathy development and evolution. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.